Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
4
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
drug prices
immunotherapy
merck
pfizer
abbvie
cancer
cell therapy
clinical trials
diagnostics
eli lilly
What
drug
bio
new
price
roundup
advantages
airport
annual
apocalypse
approval
away
bar
beds
biogen’s
biopharmaceutical
bringing
brings
celgene
ceos
companies
convo
days
dc
earlier
executives
expect
failures
fallout
gamble
gathered
gone
groups
hearing
held
home
j.p
jpm
littered
lower
market
Language
unset
Current search:
novartis
×
medicare
×
" bristol-myers squibb "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
